Brands: Jardiance · Empagliflozin
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | unknown | 8 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | unknown | 8 | SUPPLYING |
| A-S Medication Solutions | unknown | 6 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Labeling: Label Mix-up — Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc. — Product was distributed nationwide within the United States and PR
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. — Recalling firm: CARDINAL HEALTHCARE — Nationwide USA
Pill